November 29, 2018

Fresenius Kabi is Among the Most Reputable Companies in Germany
read more

November 9, 2018

Watch now: A young man describes the challenges of living with parenteral nutrition and encourages others who are in a similar situation
read more

October 30, 2018

Fresenius in Q3/18 with continued strong Group earnings growth in constant currency
read more

October 19, 2018

Two Decades as Exceptional Instructor: How Eric Wieschmann creates a reliable pool of talented engineers for Fresenius Kabi
read more

October 18, 2018

Fresenius Kabi reaches a global agreement with AbbVie regarding Fresenius Kabi’s adalimumab, MSB11022, a biosimilar candidate of AbbVie’s Humira®
read more

October 12, 2018

Fresenius Kabi opens compounding center in Canada
read more

October 9, 2018

Fresenius Kabi’s pegfilgrastim biosimilar candidate MSB11455 met its primary endpoints in the two pivotal clinical studies
read more

August 10, 2018

Fresenius Kabi is one of the Best Workplaces in the field of Biotechnology, Pharmaceuticals & Healthcare Industry in India
read more

July 31, 2018

Fresenius posts strong second quarter and confirms Group guidance – Continued net income growth – EBIT outlook raised for Fresenius Kabi
read more

June 22, 2018

Fresenius Kabi UK expands operations in Runcorn, England
read more

June 21, 2018

Melrose Park Topping Out Ceremony
read more

June 8, 2018

Donating Blood Helps Saving Lives
read more

June 6, 2018

Fresenius Kabi Australia is the type to save lives
read more

June 1, 2018

Fresenius Kabi opens new laboratory and office areas at its Innovation & Development Center in Graz, Austria
read more

May 28, 2018

New EU Commission’s initiative “SPC manufacturing waiver”
read more

May 16, 2018

Fresenius Kabi is one of the Best Employers in the Czech Republic
read more

May 9, 2018

Fresenius Kabi USA participates in “Be The Match Walk+Run”
read more

May 3, 2018

Fresenius makes excellent start to 2018, with strong sales and net income growth in constant currency
read more

April 20, 2018

Fresenius Kabi expands production site for medical devices in Dominican Republic
read more

April 13, 2018

Taking on Responsibility
read more

March 23, 2018

Fresenius Kabi makes donation to a school in Thailand
read more

March 16, 2018

Fresenius Kabi India is certified as a Great Place to Work for in 2018
read more

February 26, 2018

Fresenius reports 14th consecutive record year, aims at strong growth in 2018 and confirms mid-term growth targets
read more

February 9, 2018

The life-changing application: 20 years of loyalty and intense experiences
read more

January 29, 2018

HES solutions should remain on the market
read more

January 22, 2018

Fresenius Kabi’s blood bag plant in Guangzhou, China, celebrates 10th anniversary
read more

December 20, 2017

Calea UK and University Hospital Wales support home parenteral nutrition patients
read more

December 18, 2017

Fresenius Kabi Submits its First Biosimilar Marketing Authorization Application to European Medicines Agency for MSB11022, a biosimilar of adalimumab
read more

December 11, 2017

Fresenius Kabi Germany supports the “wish van” project with Christmas donation
read more

December 1, 2017

Fresenius Kabi opens extension at production plant in Mihla, Germany
read more

November 24, 2017

Fresenius Kabi opens production facility in Indonesia
read more

November 23, 2017

Fresenius Kabi Austria receives “Excellent Company for Learning in Europe” award
read more

November 2, 2017

Fresenius reports another strong quarter and confirms guidance
read more

October 10, 2017

Fresenius Kabi’s Generic Drugs Business Unit Head elected as president of Medicines for Europe
read more

October 10, 2017

Running for patients: Fresenius Kabi Poland goes the extra mile
read more

September 26, 2017

Fresenius Kabi Breaks Ground on $250 million Expansion of Pharmaceutical Manufacturing Site in Illinois
read more

September 25, 2017

Employees of Fresenius Kabi China donate blood together
read more

September 8, 2017

Fresenius Kabi marks 20-year anniversary of Friedberg production site – Logistics center expansion planned
read more

September 6, 2017

Fresenius Kabi Germany supports trainees in geriatric and nursing care
read more

September 1, 2017

Fresenius Kabi completes acquisition of Merck KGaA’s biosimilars business
read more

August 1, 2017

Fresenius confirms its guidance after a strong second quarter with double-digit sales and earnings growth
read more

July 20, 2017

Akorn shareholders approve merger agreement with Fresenius Kabi - Closing expected latest by early 2018
read more

July 6, 2017

Fresenius Kabi expands production site in Portugal
read more

May 3, 2017

Fresenius is off to an excellent start to the year with strong sales and earnings growth
read more

April 24, 2017

Fresenius Kabi to strengthen and diversify product portfolio by acquiring Akorn and Merck KGaA’s biosimilars business
read more

April 4, 2017

Award as “Great Place to Work” in the Dominican Republic
read more

April 3, 2017

Representative of the U.S. Congress visits the Maricao plant in Puerto Rico
read more

March 20, 2017

Fresenius Kabi welcomes Portuguese Minister of Health
read more

March 10, 2017

Fresenius Kabi builds new warehouse at Blonie production site
read more

February 22, 2017

Fresenius reports 13th consecutive record year and targets continued strong growth
read more

December 21, 2016

Fresenius Kabi Germany supports Blindeninstitut Thüringen (Thuringia Institute for the Blind) with Christmas donation
read more

October 27, 2016

Fresenius: Continued strong sales and earnings growth; Lower end of Group earnings guidance raised
read more

October 12, 2016

Fresenius Kabi wins award for nutritional therapy website
read more

September 22, 2016

"I want to help others, so they won’t give up" – Living on parenteral nutrition
read more

September 9, 2016

Fresenius Kabi expands production site in Mihla, Germany
read more

August 17, 2016

Fresenius Kabi investing nearly $250 million to expand plant near Chicago
read more

August 1, 2016

Fresenius raises earnings guidance after strong second quarter; Double-digit earnings growth
read more

June 27, 2016

Fresenius appoints Stephan Sturm as new Chief Executive Officer – Ulf Mark Schneider leaves the company to pursue another opportunity
read more

June 16, 2016

Fresenius Kabi USA honored for helping disaster survivors
read more

May 3, 2016

Strong start into the year – Double-digit earnings growth in constant currency – Fresenius confirms Group guidance for 2016
read more

February 24, 2016

Fresenius: Outstanding 2015 financial results – 25% dividend increase proposed – Positive outlook for 2016 – New mid-term growth targets
read more

January 8, 2016

Fresenius Kabi acquires Ready-to-Administer Drugs and U.S. Pharmaceutical Plant from Becton Dickinson
read more

December 4, 2015

Improving the lives of the youth in South Africa
read more

November 5, 2015

Fresenius Kabi enhances school facilities in India
read more

October 29, 2015

Continued strong sales and net income growth - Fresenius raises Group earnings guidance for 2015
read more

July 29, 2015

Accelerating sales and earnings growth in Q2 – Fresenius raises Group earnings guidance for 2015
read more

April 29, 2015

Strong start into the year – Double-digit growth in constant currency – Fresenius raises Group earnings guidance for 2015
read more

April 9, 2015

Fresenius Kabi supports medical relief in Gaza and Syria
read more

February 25, 2015

Fresenius: Sales and net income reach all-time highs - 6% dividend increase proposed - Positive Group outlook for 2015
read more

February 16, 2015

Fresenius Kabi sells German oncology compounding business
read more

January 26, 2015

Fresenius Kabi and Halyard Health enter Supply and Distribution Agreement for Halyard Health Elastomeric I.V. Infusion Pumps
read more

January 12, 2015

Fresenius Kabi Receives FDA Status Upgrade for US Grand Island Facility
read more

November 17, 2014

Sierra Leone Action Receives Donation of Transfusion Medicine Equipment from Fresenius Kabi
read more

November 6, 2014

Fresenius Kabi and Russian partners terminate joint venture agreement
read more

November 4, 2014

Fresenius posts strong Q3 results and confirms 2014 Group outlook
read more

September 8, 2014

Blood Collectors Week Celebrates Professionals Who Support the Blood Supply
read more

July 31, 2014

Accelerated growth in Q2 - Fresenius raises FY 2014 sales outlook, fully confirms earnings outlook
read more

May 9, 2014

Fresenius Kabi expands I.V. drug business in Latin America
read more

May 6, 2014

Fresenius reports expected moderate Q1 2014, fully confirms FY 2014 outlook
read more

April 25, 2014

Fresenius Kabi enters Russian joint venture
read more

February 25, 2014

Fresenius: Group net income at top end of guidance, exceeding €1 billion – Positive Group outlook for 2014 – New mid-term Group targets
read more

November 5, 2013

Continued strong sales and net income growth – Fresenius fully confirms 2013 outlook
read more

October 2, 2013

Fresenius Kabi starts joint venture on I.V. generics in Indonesia
read more

August 19, 2013

Fresenius Kabi enters joint venture on I.V. generics in Indonesia
read more

July 30, 2013

Fresenius announces record results, raises 2013 Group earnings guidance
read more

July 25, 2013

Fresenius Kabi receives 60601-1 3rd Edition Certification for Aurora Plasmapheresis System
read more

May 31, 2013

Fresenius Kabi at the ISBT in Amsterdam
read more

April 30, 2013

Successful start into 2013 – Fresenius fully confirms outlook
read more

February 26, 2013

Fresenius: Centennial year with record sales and earnings – Group net income exceeds guidance – Positive outlook for 2013
read more

December 17, 2012

Fresenius Kabi sells respiratory homecare business in France
read more

December 14, 2012

Fresenius Kabi completes acquisition of Fenwal Holdings, Inc.
read more

October 31, 2012

Fresenius reports strong sales and earnings growth in the first three quarters and fully confirms 2012 outlook
read more

September 5, 2012

Fresenius Kabi raises 2012 outlook
read more

August 1, 2012

Fresenius reports excellent sales and earnings growth, fully confirms 2012 outlook
read more

July 20, 2012

Fresenius Kabi acquires Fenwal Holdings, Inc.
read more

June 11, 2012

Fresenius Kabi Capital Market Day: 2012 outlook raised amid excellent prospects for continued growth
read more

May 3, 2012

Excellent start into 2012 – Fresenius raises outlook
read more

March 9, 2012

Fresenius Announces Management Board Changes
read more

February 21, 2012

Fresenius achieves record sales and earnings in 2011 – Strong growth expected in all business segments for 2012
read more

December 2, 2011

Fresenius Kabi announces Changes in the Management Board
read more

November 2, 2011

Fresenius achieves record Q3 earnings − improves 2011 earnings outlook
read more

September 26, 2011

Fresenius opens new production facility in Vietnam
read more

August 2, 2011

Fresenius: Excellent sales and earnings growth − Fresenius raises earnings outlook
read more

May 4, 2011

Fresenius: Excellent start into 2011 − Fresenius raises 2011 sales and earnings outlook
read more

February 23, 2011

Fresenius: Record results in 2010: All financial targets met or exceeded – Positive outlook for 2011
read more

November 11, 2010

Fresenius Kabi and Boehringer Ingelheim RCV successfully coupled HES to a therapeutic protein in an industrial scale applying Fresenius Kabi’s HESylation® Technology
read more

November 2, 2010

Fresenius reports excellent sales and earnings growth – Raises outlook
read more

August 3, 2010

Fresenius SE: Excellent sales and earnings growth – Earnings outlook raised
read more

July 27, 2010

Fresenius SE: First half of 2010: Preliminary Group net income substantially better than expected − Earnings outlook raised
read more

May 4, 2010

Fresenius SE: Q1 2010: Successful start into 2010 − Outlook fully confirmed
read more

March 26, 2010

MNI Grant for the Best Initiative to Fight Malnutrition
read more

February 24, 2010

Fresenius SE: Record financial results in 2009 − All financial targets met or exceeded − Positive outlook for 2010
read more

January 27, 2010

Fresenius Group’s initial relief assists over 185,000 Haiti earthquake victims
read more

January 13, 2010

Fresenius Kabi and Bayer Schering Pharma extend collaboration regarding HESylation® Technology
read more

November 3, 2009

Fresenius SE: Q1-3/2009: Strong organic sales growth achieved - Outlook for 2009 fully confirmed
read more

October 28, 2009

Fresenius Kabi and Octapharma Group enter into an Exclusive License, Development and Supply Agreement for a HESylated recombinant protein
read more

August 4, 2009

Fresenius SE: H1 2009: Maintains growth momentum: Confirms outlook
read more

May 18, 2009

Fresenius Kabi and Bayer Schering Pharma enter into a Research, Development and License Agreement regarding HESylation® Technology
read more

April 30, 2009

Fresenius SE: Q1 2009: Successful start into 2009
read more

February 19, 2009

Fresenius SE: Successful 2008 − Financial targets fully met or exceeded − Positive outlook for 2009
read more

November 4, 2008

Fresenius SE: Q1-3/2008: Continued strong growth − Sales outlook raised
read more

September 10, 2008

Fresenius closes APP acquisition
read more

September 2, 2008

Fresenius and APP Pharmaceuticals Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
read more

August 11, 2008

Acquisition of Dabur Pharma successfully closed
read more

July 30, 2008

Fresenius SE: First half 2008 - Strong financial results
read more

July 17, 2008

Strong financial results in the first half of 2008 (preliminary figures)
read more

July 7, 2008

Fresenius Kabi to acquire APP Pharmaceuticals – entry into North American I.V. generics market provides excellent growth opportunities
read more

April 30, 2008

Fresenius SE: Q1 2008 - Successful start into 2008
read more

April 20, 2008

Fresenius Kabi strengthens its position in i.v. drugs by acquiring Dabur Pharma, a leading manufacturer of oncology generics
read more

February 20, 2008

Fresenius achieves record financial results in 2007 Positive outlook for 2008
read more

December 11, 2007

Fresenius Kabi acquires leading European manufacturer of antibiotic agents and strengthens its position in the area of intravenously administered generic drugs
read more

December 7, 2007

Fresenius Kabi expands infusion therapy business in Latin America
read more

November 26, 2007

Fresenius Kabi continues growth strategy and strengthens its Clinical Nutrition business
read more

October 31, 2007

Fresenius SE - Q1-3 2007: Excellent sales and earnings growth in all business segments – Strong third quarter – Outlook raised
read more

August 2, 2007

Fresenius SE - First half 2007: Fresenius reports continued growth in sales and earnings and raises full-year earnings outlook
read more

May 2, 2007

Fresenius AG - Q1 2007: Successful start to 2007
read more

February 22, 2007

Fresenius AG: Fiscal Year 2006
read more

October 31, 2006

Fresenius AG - First nine months 2006: Excellent sales and earnings growth in all business segments – Strong third quarter – Outlook raised
read more

October 11, 2006

Fresenius plans conversion into European Company (SE) and share split
read more

August 3, 2006

Fresenius AG: First half of 2006
read more

May 3, 2006

Fresenius AG: First quarter 2006
read more

February 22, 2006

Fresenius AG: Fiscal Year 2005
read more

January 3, 2006

Fresenius Kabi raises its stake in Pharmatel Fresenius Kabi Pty Ltd. to 50.1%
read more

November 3, 2005

Fresenius AG: Excellent financial results in the 1st- 3rd quarter of 2005; full year outlook confirmed
read more

November 1, 2005

Peter Fürst Research Prize
read more

October 14, 2005

Fresenius continues profitable growth: Acquisition of Clinico to develop Fresenius Kabi's medical devices business
read more

August 4, 2005

First half of 2005: Fresenius achieves excellent financial results and raises full-year earnings outlook
read more

June 27, 2005

Fresenius Kabi and Pall enter Agreement to Accelerate Adoption of Prion Reduction Technology
read more

May 4, 2005

First Quarter 2005: Excellent start for Fresenius Group into fiscal year 2005
read more

March 17, 2005

Fresenius Kabi recognized by Frost & Sullivan for Competitive Strategy Leadership in Clinical Nutrition
read more

March 16, 2005

Fresenius Kabi closed acquisition of I.V. drug company Labesfal
read more

March 2, 2005

Fresenius Kabi strengenths position in China - increases stake in joint venture from 65% to 100%
read more

February 24, 2005

Excellent business performance in 2004; Positive outlook for 2005
read more

January 7, 2005

Fresenius Kabi continues growth strategy and acquires I.V. drug company
read more

December 8, 2004

Fresenius Kabi: Market leader builds on success
read more

December 7, 2004

Fresenius Kabi strengenths position in central and eastern europe
read more

September 6, 2004

Fresenius Kabi is expanding its market presence in Australia
read more

Congresses

Congresses

March 6 - 9, 2019 | Denmark, Copenhagen

ECCO

Link to ECCO Website
March 19 - 22, 2019 | Belgium, Brussels

ISICEM

Link to ISICEM Website
March 23 - 26, 2019 | USA, Phoenix, Arizona

ASPEN

Link to ASPEN Website
March 24 - 27, 2019 | Germany, Frankfurt

EBMT

Link to EBMT Website
March 27 - 29, 2019 | Spain, Barcelona

EAHP

Link to EAHP Website
April 4 - 5, 2019 | Germany, Berlin

NATA

Link to NATA Website
June 1 - 3, 2019 | Austria, Vienna

ESA

Link to ESA Website

Contact News

At Fresenius Kabi, we welcome your questions, comments and requests. Please fill in the contact form or get in touch with us directly.

Contact Us

Ursula Schneider Ursula Schneider
Senior Vice President Corporate Communications
+49 6172 686-2627

Nicole Weber Nicole Weber
Vice President Corporate Communications
+49 6172 686-2394